Lung Cancer Smoking Status Impact and EGFR TKI/Angiogenesis inhibitor combination therapy in aNSCLC. Apr 17, 2023
Lung Cancer Dabrafenib + Trametinib: Clincal trial vs SOC in BRAF-Mutated aNSCLC Patients Apr 17, 2023
Lung Cancer COAST: Durvalumab + Oleclumab/Monalizumab Therapy in Patients with Unresectable NSCLC Apr 17, 2023
Lung Cancer ATEZO-BRAIN: Atezolizumab Plus Carboplatin & Pemetrexed in NSCLC with untreated Brain Metastases Apr 17, 2023
Lung Cancer Efficacy and Safety of Pemigatinib in Pan-Cancer have an Acceptable Safety Profile: FIGHT-101 Apr 17, 2023
Lung Cancer Neoadjuvant Sintilimab Plus Chemotherapy: Two Cycles vs. Three for Resectable NSCLC Apr 17, 2023
